Earlier Reported 'ADHD Drug Shortages Worsen As Makers Say Production Is Maxed Out' - Bloomberg
Portfolio Pulse from Benzinga Newsdesk
According to Bloomberg, ADHD drug shortages are worsening as manufacturers Teva, Novartis, and Takeda have announced that their production is maxed out.
September 12, 2023 | 1:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Teva Pharmaceutical Industries Ltd. is one of the companies that has reached its production limit for ADHD drugs, potentially affecting its revenue and stock price.
Teva's announcement of reaching its production limit for ADHD drugs could lead to a decrease in revenue if the demand continues to exceed supply. This could negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100